Iodine-125_seed_implantation_as_an_adjunct_to_surgery_in_advanced_recurrent_squamous_cell_cancer_of_the_head_and_neck._Survival_for_extensive_recurrent_squamous_cell_carcinomas_of_the_head_and_neck_remains_poor,_with_the_major_cause_of_death_being_local_recurrence._Surgical_implantation_of_iodine-125_interstitial_seeds_allows_tumoricidal_doses_of_radiation_to_be_delivered_to_residual_tumor_while_minimizing_radiation_doses_to_the_surrounding_tissues._From_1978_to_1988,_39_implantations_were_performed_on_35_patients_for_extensive_recurrent_squamous_cell_carcinoma_of_the_head_and_neck._The_decision_for_implantation_was_based_on_positive_margins_or_close_to_resection_margins_from_frozen_sections_after_salvage_resection._The_determinate_5-year_disease-free_survival_was_41%,_with_both_the_overall_and_no_evidence_of_disease_5-year_survivals_being_29%._Significant_complications_occurred_in_36%_of_all_cases._This_figure_increased_to_56%_when_flap_reconstruction_was_required._Possible_reasons_for_this_seemingly_high_complication_rate_are_discussed._Considering_the_advanced_nature_of_these_recurrent_carcinomas,_surgical_resection_with_iodine-125_seed_implantation_appears_to_be_an_effective_method_of_managing_disease_that_might_otherwise_be_judged_unresectable_and_treated_for_palliation_only.